Mallinckrodt sues U.S. health agencies, sees 10% hit to MS treatment sales
Mallinckrodt Plc filed a lawsuit against the U.S. Department of Health and Human Services and forecast an about 10% hit to annual net sales of its gel used to treat multiple sclerosis symptoms following changes to Medicaid rebate calculations, sending shares plunging as much as 34% on Tuesday.
from Reuters: Health News https://reut.rs/2YHyPwu
http://bit.ly/2zwRqiM